AA

Anupama Ajit Godbole

Active Director Director DIN 02507423
DIN 02507423 First appointment Feb 2005 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2005
Shareholding value •••• Premium profile

About Anupama Ajit Godbole

Data last updated:

Anupama Ajit Godbole is a Director at Anant Pharmaceuticals Private Limited (since 2005). The company operates in Pharma. Anant Pharmaceuticals Private Limited reported revenue of ₹6.76 Cr (FY 2025).

DIN 02507423
Primary Designation Director
Industry Pharma
First Appointment 18 Feb 2005
Oldest Company Age 21 yrs
Largest company Anant Pharmaceuticals Private Limited · ₹6.76 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Feb 20052005₹6.76 Cr (FY 2025)Active

Board colleagues of Anupama Ajit Godbole

Directorship timeline

Open interactive timeline →
Anant Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Anupama Ajit Godbole

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anupama Ajit Godbole

Anupama Ajit Godbole currently holds 1 directorship: Anant Pharmaceuticals Private Limited (Director, since 18 Feb 2005, revenue ₹6.76 Cr (FY 2025)).

Anupama Ajit Godbole was first appointed on 18 Feb 2005 as Director at Anant Pharmaceuticals Private Limited.

The current boards of Anupama Ajit Godbole's companies include Ajit Anil Godbole (Anant Pharmaceuticals Private Limited), Anil Shankar Godbole (Anant Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available